DRL Q1FY20 earnings: Margins to remain stable between 20% & 21% due to cost rationalisation measures

DRL Q1FY20 earnings: Margins to remain stable between 20% & 21% due to cost rationalisation measures

Dr Reddy's Laboratories (DRL) will be reporting its Q1FY20 numbers today. Here are key expectations.


User: CNBC-TV18

Views: 105

Uploaded: 2019-07-29

Duration: 01:47

Your Page Title